Medizinische Universität Graz - Research portal
Navigation/Search
- Researchers
- Institutions
- Projects
- Publications
- Partners
- Sponsors
- Equipment
- Knowhow
- Fields of Research
"Faces" of the day:
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Marsche, G; Weigle, B; Sattler, W; Malle, E.
Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein.
FASEB J. 2007; 21(12): 3075-3082.
Doi: 10.1096/fj.07-8316com
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Leading authors Med Uni Graz
- Malle Ernst
- Marsche Gunther
- Co-authors Med Uni Graz
- Sattler Wolfgang
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Engagement of the receptor for advanced glycation end products (RAGE) by its signal transduction ligands evokes inflammatory cell infiltration and activation of the vessel wall. However, soluble RAGE (sRAGE), the truncated form spanning the extracellular binding domain of RAGE, has potent anti-inflammatory properties by acting as a decoy for RAGE ligands. We now show that sRAGE binds with high affinity to atherogenic low-density lipoprotein (LDL) modified by hypochlorous acid (HOCl), the major oxidant generated by the myeloperoxidase-H2O2-chloride system of phagocytes activated during inflammation. We further demonstrate that sRAGE can be coprecipitated with HOCl-LDL from spiked serum. To determine the functional significance of sRAGE binding to HOCl-LDL, cell association studies with macrophages were performed. sRAGE effectively inhibited cellular uptake of HOCl-LDL and subsequent lipid accumulation. Using Chinese hamster ovary cells overexpressing class B scavenger receptor CD36 or SR-BI, two preferential scavenger receptors for HOCl-LDL, we demonstrate that sRAGE only interferes with CD36-mediated uptake of HOCl-LDL. The present findings indicate that sRAGE acts as a sink for HOCl-LDL, which is abundantly present in human atherosclerotic lesions. We propose that sRAGE represents a physiological antagonist that interferes with scavenger receptor-mediated cholesterol accumulation and foam cell formation of macrophages.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Atherosclerosis - metabolism
- Cell Line - metabolism
- Cricetinae - metabolism
- Cricetulus - metabolism
- Glycosylation End Products, Advanced - metabolism
- Humans - metabolism
- Hypochlorous Acid - metabolism
- Lipoproteins, LDL - metabolism
- Macrophages - cytology
- Mice - cytology
- Oxidants - metabolism
- Peptide Fragments - genetics
- Protein Binding - genetics
- Receptors, Immunologic - genetics
- Scavenger Receptors, Class B - genetics
- Find related publications in this database (Keywords)
- myeloperoxidase
- inflammation
- oxidized LDL
- foam cells